10th Feb 2010 10:00
RNS Number : 9414G
AGI Therapeutics plc
10 February 2010
AGI Therapeutics plc ('AGI')
Holding in Company
AGI was notified on 9 February 2010 that Edinburgh Partners Limited, having assumed management of certain funds previously managed by F&C Management Limited, had decreased its shareholding to 2,969,576 Ordinary Shares representing 4.41% of AGI's Issued Share Capital.
Contact Information
AGI Therapeutics
David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Potentially Ai